These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 17666816)

  • 1. Tissue distribution and hepatic subcellular distribution of perfluorooctanoic acid at low dose are different from those at high dose in rats.
    Kudo N; Sakai A; Mitsumoto A; Hibino Y; Tsuda T; Kawashima Y
    Biol Pharm Bull; 2007 Aug; 30(8):1535-40. PubMed ID: 17666816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subcellular distribution and protein binding of perfluorooctanoic acid in rat liver and kidney.
    Han X; Kemper RA; Jepson GW
    Drug Chem Toxicol; 2005; 28(2):197-209. PubMed ID: 15865261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue distribution, metabolism, and elimination of perfluorooctanoic acid in male and female rats.
    Vanden Heuvel JP; Kuslikis BI; Van Rafelghem MJ; Peterson RE
    J Biochem Toxicol; 1991; 6(2):83-92. PubMed ID: 1941903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue distribution of
    Bogdanska J; Borg D; Bergström U; Mellring M; Bergman Å; DePierre J; Nobel S
    Chemosphere; 2020 Jan; 239():124755. PubMed ID: 31726523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing models for perfluorooctanoic acid pharmacokinetics using Bayesian analysis.
    Wambaugh JF; Barton HA; Setzer RW
    J Pharmacokinet Pharmacodyn; 2008 Dec; 35(6):683-712. PubMed ID: 19130186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depuration kinetics and tissue disposition of PFOA and PFOS in white leghorn chickens (Gallus gallus) administered by subcutaneous implantation.
    Yoo H; Guruge KS; Yamanaka N; Sato C; Mikami O; Miyazaki S; Yamashita N; Giesy JP
    Ecotoxicol Environ Saf; 2009 Jan; 72(1):26-36. PubMed ID: 18006059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations by perfluorooctanoic acid of glycerolipid metabolism in rat liver.
    Kudo N; Mizuguchi H; Yamamoto A; Kawashima Y
    Chem Biol Interact; 1999 Mar; 118(1):69-83. PubMed ID: 10227579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of PFOA in dosed CD1 mice. Part 1. Methods development for the analysis of tissues and fluids from pregnant and lactating mice and their pups.
    Reiner JL; Nakayama SF; Delinsky AD; Stanko JP; Fenton SE; Lindstrom AB; Strynar MJ
    Reprod Toxicol; 2009 Jun; 27(3-4):360-364. PubMed ID: 19028561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the toxicological effects of PFOA and PFOS on rats using histological observation and chemical analysis.
    Cui L; Zhou QF; Liao CY; Fu JJ; Jiang GB
    Arch Environ Contam Toxicol; 2009 Feb; 56(2):338-49. PubMed ID: 18661093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absorption, distribution, and milk secretion of the perfluoroalkyl acids PFBS, PFHxS, PFOS, and PFOA by dairy cows fed naturally contaminated feed.
    Kowalczyk J; Ehlers S; Oberhausen A; Tischer M; Fürst P; Schafft H; Lahrssen-Wiederholt M
    J Agric Food Chem; 2013 Mar; 61(12):2903-12. PubMed ID: 23441933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the elimination between perfluorinated fatty acids with different carbon chain length in rats.
    Kudo N; Suzuki E; Katakura M; Ohmori K; Noshiro R; Kawashima Y
    Chem Biol Interact; 2001 Apr; 134(2):203-16. PubMed ID: 11311214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transfer of perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) from contaminated feed into milk and meat of sheep: pilot study.
    Kowalczyk J; Ehlers S; Fürst P; Schafft H; Lahrssen-Wiederholt M
    Arch Environ Contam Toxicol; 2012 Aug; 63(2):288-98. PubMed ID: 22453775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxicity and toxicokinetics of perfluorooctanoic acid in humans and animals.
    Kudo N; Kawashima Y
    J Toxicol Sci; 2003 May; 28(2):49-57. PubMed ID: 12820537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gender differences in pharmacokinetics and tissue distribution of 3 perfluoroalkyl and polyfluoroalkyl substances in rats.
    Kim SJ; Heo SH; Lee DS; Hwang IG; Lee YB; Cho HY
    Food Chem Toxicol; 2016 Nov; 97():243-255. PubMed ID: 27637925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative toxicological investigation of perfluorocarboxylic acids in rats by fluorine-19 NMR spectroscopy.
    Goecke CM; Jarnot BM; Reo NV
    Chem Res Toxicol; 1992; 5(4):512-9. PubMed ID: 1391617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic modeling of perfluorooctanoic acid during gestation and lactation in the mouse.
    Rodriguez CE; Setzer RW; Barton HA
    Reprod Toxicol; 2009 Jun; 27(3-4):373-386. PubMed ID: 19429408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physiologically based pharmacokinetic modeling of human exposure to perfluorooctanoic acid suggests historical non drinking-water exposures are important for predicting current serum concentrations.
    Worley RR; Yang X; Fisher J
    Toxicol Appl Pharmacol; 2017 Sep; 330():9-21. PubMed ID: 28684146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Permeability-Limited Physiologically Based Pharmacokinetic (PBPK) Model for Perfluorooctanoic acid (PFOA) in Male Rats.
    Cheng W; Ng CA
    Environ Sci Technol; 2017 Sep; 51(17):9930-9939. PubMed ID: 28759222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of sterol regulatory element-binding proteins in mice exposed to perfluorooctanoic acid for 28 days.
    Yan S; Wang J; Dai J
    Arch Toxicol; 2015 Sep; 89(9):1569-78. PubMed ID: 25092180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal excretion of perfluorooctanoic acid in male rats: inhibitory effect of testosterone.
    Vanden Heuvel JP; Davis JW; Sommers R; Peterson RE
    J Biochem Toxicol; 1992; 7(1):31-6. PubMed ID: 1375295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.